Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Nature Medicine1996Vol. 2(8), pp. 864–870
Citations Over TimeTop 1% of 1996 papers
Donalyn Scheuner, Christopher B. Eckman, M. Jensen, X.H. Song, Martin Citron, Nobuhiro Suzuki, Thomas D. Bird, John Hardy, M. Hutton, Walter A. Kukull, Eric B. Larson, Ephrat Levy‐Lahad, Matti Viitanen, Elaine R. Peskind, Parvoneh Poorkaj, Gerald D. Schellenberg, Rudolph E. Tanzi, Wilma Wasco, Lars Lannfelt, Dennis J. Selkoe, Samuel Younkin
Related Papers
- → Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice(2002)238 cited
- → Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression(2016)117 cited
- → Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment(2005)60 cited
- → The value of transgenic and gene targeted models for experimental therapeutics of Alzheimer's disease(2002)
- Interaction between presenilins and amyloid precursor protein and production of the A_β(1999)